Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Uterine Cervical Neoplasms 18Endometrial Neoplasms 4Prostatic Neoplasms 3Sarcoma 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neuroectodermal Tumors, Primitive, Peripheral 2Esophageal Neoplasms 2Endometrial Clear Cell Adenocarcinoma 2Vaginal Neoplasms 1Uveitis 1Uveal Melanoma 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Radiation Injuries 1Obesity 1Neurotoxicity Syndromes 1Neoplasms, Unknown Primary 1Malignant mesenchymal tumor 1Lung Neoplasms 1Locally Advanced Cervical Cancer 1Locally Advanced Cervical Adenocarcinoma 1Liver Neoplasms 1Liposarcoma 1Hyperthermia 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Head and Neck Neoplasms 1Fibrosarcoma 1Fatigue 1Esophageal Squamous Cell Carcinoma 1

Interventions

Surgical Procedures, Operative 1Drug Therapy 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Directly Observed Therapy × Brachytherapy × Clear all
NCT06350825 2024-04-05

Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients

The First Affiliated Hospital with Nanjing Medical University

Phase 3 Recruiting
200 enrolled
Genitourinary

Prostatic Neoplasms, Directly Observed Therapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡